Get a Mesothelioma Treatment Guide

Find a Top Mesothelioma Doctor

Access Help Paying for Treatment

Gemzar (gemcitabine) is a chemotherapy drug used to treat mesothelioma. It shrinks tumors and improves symptoms. Often combined with other chemo drugs like cisplatin, it helps some patients live longer. A mesothelioma specialist can determine if gemcitabine is the best treatment for you.
Gemzar is the brand name for the chemotherapy drug gemcitabine, which is used to treat mesothelioma. Doctors use it to shrink tumors, slow cancer growth and lessen symptoms. It’s often used when first-line treatments, such as Alimta (pemetrexed), and other chemo regimens aren’t working as well for a patient.
Key Facts About Gemcitabine
The generic version of gemcitabine, Infugem, isn’t yet FDA-approved specifically for mesothelioma treatment. Currently Infugem is approved to treat other cancers like non-small cell lung cancer and ovarian cancer.
Gemzar (gemcitabine) stops cancer cells from making copies of their DNA. This prevents tumor growth. Doctors have long studied and used gemcitabine for people with mesothelioma.
It can be used alone or with platinum drugs. Studies show it’s particularly effective when combined with other drugs. When paired with the chemo drug cisplatin, for example, it can reduce tumors by 30%.
When used in combination with other chemo drugs, gemcitabine has shown promising results. Chemo regimens pairing Gemzar with other drugs can improve how well people respond to treatment.
Common Chemo Drugs Used With Gemzar
These combinations give people with mesothelioma more treatment options. Each one helps gemcitabine work better. This can potentially help people live longer.
Treatment with Gemzar takes a few hours and can be done as an outpatient in a doctor’s office, clinic or hospital. The drug is given via IV over the course of 30 minutes.
Your dose will be based on your body size. Your doctor will calculate the right amount for you.
The most common schedule is 1 time per week for 3 weeks and then 1 week off. You’ll typically take your medicine on days 1, 8 and 15 of a 4-week cycle. Your doctor will monitor your blood cell count regularly to manage risks like anemia or infection.
Get a Mesothelioma Treatment Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Gemzar provides several benefits for mesothelioma patients such as shrinking tumors, managing symptoms and improving survival. Gemcitabine is a valuable option for boosting outcomes.
Primary Benefits of Gemcitabine
Gemcitabine is an important part of mesothelioma treatment. It’s especially helpful for people looking for other options when regular treatments don’t work for them. While chemo can help, it may also harm healthy cells, causing side effects.
The most common side effects of gemcitabine are nausea and flu-like symptoms. Gemzar may also increase your risk of infection because chemo drugs can harm your immune system. You may need to avoid people who might be sick while undergoing treatment.
Talk to your doctor about ways to manage side effects, like medicine or making lifestyle changes. Staying in touch with your health care team can make chemotherapy easier, reducing or even preventing discomfort.
Tips for Managing Gemzar Side Effects
Some people tolerate chemo well. Kevin Hession, a pleural mesothelioma survivor, discussed his chemo experience with us sharing, “I’ve never had a bad experience with chemo. I take a steroid that gives me 48 hours of protection from nausea, and it works like a charm. My worst case on a scale of 1 to 10 has probably been a 3.”
Ongoing clinical trials continue to explore gemcitabine’s effectiveness in treating mesothelioma. Researchers are working to identify ways to enhance how well the drug works while reducing side effects.
Many studies are testing whether combining Gemzar with other treatments works better. A 2024 study showed the drug with ramucirumab helps people live longer and have fewer risks compared to gemcitabine with a placebo. This study included people whose cancer kept growing after other treatments.
Areas of Focus for Gemcitabine Trials
Previous studies tested different ways to give treatment, like longer, lower doses. One method used a 6-hour dose, which was more effective than the usual 30-minute infusion.
If you’re interested in clinical trials, speak with your mesothelioma doctor to see if you’re eligible. Participating in research studies may provide you with access to new therapies that aren’t widely available yet.
Treatment duration varies, but most mesothelioma patients receive gemcitabine for several months. This depends on tumor response and side effects.
Chemo combinations can increase effectiveness but may also raise the risk of severe side effects, such as low blood counts or kidney strain.
Depending on your overall health and treatment goals, if first-line treatments haven’t been successful for you, your doctor may prescribe gemcitabine.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2025, February 12). Gemcitabine. Asbestos.com. Retrieved February 21, 2025, from https://www.asbestos.com/treatment/chemotherapy/gemcitabine/
Selby, Karen. "Gemcitabine." Asbestos.com, 12 Feb 2025, https://www.asbestos.com/treatment/chemotherapy/gemcitabine/.
Selby, Karen. "Gemcitabine." Asbestos.com. Last modified February 12, 2025. https://www.asbestos.com/treatment/chemotherapy/gemcitabine/.
Dr. Jeffrey Velotta is an experienced thoracic surgeon and pleural mesothelioma specialist at Kaiser Permanente Oakland Medical Center in California. Velotta also serves as an assistant professor at the University of California, San Francisco.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.